Grants to Support Investigator-Initiated Early-Phase Clinical Trials in Arkansas (USA)
GrantID: 64183
Grant Funding Amount Low: $250,000
Deadline: October 2, 2026
Grant Amount High: $1,515,000
Summary
The grant aims to accelerate the development of innovative treatments and diagnostic tools for heart, lung, blood, and sleep (HLBS) conditions. The program seeks to catalyze breakthroughs in HLBS research, ultimately improving patient outcomes and advancing medical knowledge...
If you are located in Arkansas and working in the area of Awards, this funding opportunity may be a good fit. For more relevant grant options that support your work and priorities, visit The Grant Portal and use the Search Grant tool to find opportunities.
Eligible Regions
Interests
Eligible Requirements
